In rare instances, AstraZeneca’s Covid-19 vaccine linked to blood clots, regulators say
The European Medicines Agency has concluded there is a link between AstraZeneca’s Covid-19 vaccine and rare but dangerous clotting events reported in a number of countries where the vaccine has been used, events which in some cases have been fatal.
A safety committee, the agency said Wednesday, concluded that “unusual blood clots with low blood platelets should be listed as very rare side effects” of the vaccine.
